Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
1.880
-0.080 (-4.08%)
Dec 30, 2024, 12:36 PM EST - Market open
Dyadic International Employees
Dyadic International had 7 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
$480,650
Profits / Employee
-$904,297
Market Cap
55.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
DYAI News
- 5 weeks ago - Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology - GlobeNewsWire
- 6 weeks ago - Dyadic International, Inc. (DYAI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - GlobeNewsWire
- 2 months ago - Dyadic Expands Global Presence with Participation in Key Industry Events - GlobeNewsWire
- 3 months ago - Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference - GlobeNewsWire
- 4 months ago - Dyadic International, Inc. (DYAI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024 - GlobeNewsWire
- 6 months ago - Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership - GlobeNewsWire